7 贺茂林, 陈清棠. 急性脑梗塞尿激酶静脉溶栓治疗的初步临床观察. '96神经内科学术年会论文汇编, 1996.3-4.
8 Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992,23:632-640.
9 Haley EC Jr, Levy DE, Brott TG, et al. Urgent therapy for stroke. Part Ⅱ. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke,1992,23:641-645.
10 Haley EC Jr, Brott TG,Sheppard GL, et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke,1993,24:1000-1004.
11 Marshall RS, Mohr JP. Current management of ischaemic stroke. J Neurol Neurosurg Psychiatry, 1993,56:6-16.
12 Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis, 1992,34:235-262.
13 Sloan MA, Price TR, Petito CK, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction(TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology, 1995, 45: 649-658.
14 Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke, 1994, 25: 298-303.
15 Lyden PD, Grotta JC, Levine SR, et al. Intravenous thrombolysis for acute stroke. Neurology,1997,49:14-20.
16 魏岗之. 急性缺血性卒中的溶栓治疗. 中华神经科杂志, 1997, 30: 240-241.